Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8609 |
High Similarity |
NPD7266 |
Discontinued |
0.8418 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8383 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8377 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8208 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD37 |
Approved |
0.8092 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8092 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8084 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8081 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.807 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8061 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8061 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8059 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7977 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7937 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7882 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD7240 |
Approved |
0.787 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7733 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7597 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.743 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7381 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7317 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7253 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7194 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7179 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD27 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7022 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7022 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7011 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7011 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6989 |
Remote Similarity |
NPD4663 |
Approved |
0.6983 |
Remote Similarity |
NPD2969 |
Approved |
0.6983 |
Remote Similarity |
NPD2970 |
Approved |
0.6982 |
Remote Similarity |
NPD1511 |
Approved |
0.6977 |
Remote Similarity |
NPD3226 |
Approved |
0.6974 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6973 |
Remote Similarity |
NPD7309 |
Approved |
0.697 |
Remote Similarity |
NPD7874 |
Approved |
0.697 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6962 |
Remote Similarity |
NPD2797 |
Approved |
0.6959 |
Remote Similarity |
NPD5403 |
Approved |
0.6959 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD5691 |
Approved |
0.6944 |
Remote Similarity |
NPD4481 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD6776 |
Approved |
0.6943 |
Remote Similarity |
NPD6782 |
Approved |
0.6943 |
Remote Similarity |
NPD6778 |
Approved |
0.6943 |
Remote Similarity |
NPD6780 |
Approved |
0.6943 |
Remote Similarity |
NPD6777 |
Approved |
0.6943 |
Remote Similarity |
NPD6779 |
Approved |
0.6943 |
Remote Similarity |
NPD6781 |
Approved |
0.6941 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6933 |
Remote Similarity |
NPD7843 |
Approved |
0.6928 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7698 |
Approved |
0.6923 |
Remote Similarity |
NPD7697 |
Approved |
0.6923 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD4577 |
Approved |
0.6919 |
Remote Similarity |
NPD4578 |
Approved |
0.6915 |
Remote Similarity |
NPD7930 |
Approved |
0.691 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6909 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6909 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6909 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6908 |
Remote Similarity |
NPD7157 |
Approved |
0.6905 |
Remote Similarity |
NPD7003 |
Approved |
0.6905
|
Remote Similarity |
NPD6331 |
Phase 2 |